Meeting
Abstract Number: 338
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: High-risk patients with hematuria often warrant an outpatient evaluation for bladder cancer; however the presence of microscopic hematuria may often be missed by primary care physicians after hospital discharge. Whether outpatient physician’s routinely follow-up incidental microscopic hematuria on urinalysis performed during inpatient visits is yet to be fully elucidated. Our aim was to assess […]
Abstract Number: 610
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Case Presentation: An 88-year-old man presented with fevers, chills, weight loss, and acute confusion. The patient had a history of non invasive high grade papillary urothelial carcinoma of the bladder treated with transurethral resection of bladder tumor and intravesical Bacillus Calmette-Guérin (BCG) therapy. Symptoms occurred one year after completion of BCG therapy. His Physical Examination […]
Abstract Number: 732
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Case Presentation: Intravesical administration of Bacillus Calmette-Guerin (BCG), a live attenuated strain of Mycobacterium bovis, is used as an adjunctive therapy for superficial bladder cancer. Although mostly well tolerated, disseminated infections can occur rarely. We describe a case of Mycobacterial vertebral osteomyelitis (Pott’s disease) following BCG immunotherapy that was treated with anti-tubercular therapy. Discussion: An […]